Norepinephrine–dopamine releasing agent
It has been suggested that this article be merged with Amphetamine type stimulant. Reason: They are almost exactly the same thing. (Discuss) Proposed since November 2024. |
A norepinephrine–dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body and/or brain.
Examples of NDRAs include phenethylamine, tyramine, amphetamine, methamphetamine, lisdexamfetamine, cathinone, methcathinone, phentermine, propylhexedrine, phenmetrazine, pemoline, 4-methylaminorex, and benzylpiperazine.
NDRAs have psychostimulant effects and are used to treat medical conditions like attention-deficit hyperactivity disorder (ADHD), binge eating disorder, obesity, narcolepsy, and for other indications. They are also used to increase motivation and to enhance performance.
A closely related type of drug is a norepinephrine–dopamine reuptake inhibitor (NDRI), for instance methylphenidate.
See also
editReferences
editExternal links
edit
Media related to Norepinephrine-dopamine releasing agents at Wikimedia Commons
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |